Last reviewed · How we verify
Furosemide 20 Milligrams
Furosemide inhibits sodium and chloride reabsorption in the ascending loop of Henle, promoting diuresis and reducing fluid volume.
Furosemide inhibits sodium and chloride reabsorption in the ascending loop of Henle, promoting diuresis and reducing fluid volume. Used for Edema associated with congestive heart failure, Edema associated with hepatic cirrhosis, Edema associated with renal disease.
At a glance
| Generic name | Furosemide 20 Milligrams |
|---|---|
| Also known as | furosemide 500 milligrams, hydrochlorothiazide 25 milligrams |
| Sponsor | Instituto de Investigación Sanitaria Aragón |
| Drug class | Loop diuretic |
| Target | Na-K-2Cl cotransporter (NKCC2) |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
Furosemide is a loop diuretic that blocks the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle, preventing reabsorption of sodium, potassium, and chloride. This increases urine output and reduces total body fluid volume, lowering blood pressure and reducing edema. It is one of the most potent diuretics available.
Approved indications
- Edema associated with congestive heart failure
- Edema associated with hepatic cirrhosis
- Edema associated with renal disease
- Hypertension
- Pulmonary edema
Common side effects
- Hypokalemia
- Hyperuricemia
- Ototoxicity
- Dehydration
- Hypotension
- Hyperglycemia
Key clinical trials
- Forced Diuresis After Flexible Ureteroscopy for Medium-Sized Renal Stones (NA)
- The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure (PHASE3)
- Furosemide for Accelerated Recovery of Blood Pressure Postpartum (PHASE2)
- The Del Nido Versus Cold Blood Cardioplegia in Aortic Valve Replacement (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Furosemide 20 Milligrams CI brief — competitive landscape report
- Furosemide 20 Milligrams updates RSS · CI watch RSS
- Instituto de Investigación Sanitaria Aragón portfolio CI